A

Aptevo Therapeutics
D

APVO

0.30470
USD
-0.01
(-1.77%)
مغلق
حجم التداول
6,283
الربح لكل سهم
-12
العائد الربحي
-
P/E
-0
حجم السوق
5,640,632
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADMA
    -1.180
    (-5.84%)
    19.030 USD
    A
    APLT
    -0.32500
    (-3.61%)
    8.68000 USD
    A
    ASND
    2.160
    (1.74%)
    126.510 USD
    K
    KURA
    -0.560
    (-3.40%)
    15.920 USD
    L
    LGND
    -3.790
    (-3.28%)
    111.690 USD
    M
    MRKR
    -0.63000
    (-17.21%)
    3.03000 USD
    O
    OCUL
    -0.77000
    (-7.75%)
    9.16000 USD
    R
    RIGL
    -3.530
    (-12.78%)
    24.100 USD
    المزيد
الأخبار

العنوان: Aptevo Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.